Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. clinical data
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Videos

Refine by
Date

  • This Year
  • Older

Clinical Data Articles & Analysis

88 articles found

Monodispersed PEG Linkers Enhance Antibody–Drug Conjugates (ADCs)

Monodispersed PEG Linkers Enhance Antibody–Drug Conjugates (ADCs)

In fact, PEGylated linkers allow higher drug-to-antibody ratios (DARs) by preventing payload aggregation and rapid clearance. Clinical data show that ADCs with very high DARs (over ~6) clear quickly due to hydrophobicity, whereas optimized DARs (2–4) strike a balance of potency and half-life. ...

ByBiopharma PEG Scientific Inc


How Predictive Analytics is Boosting Clinical Trials Efficiency?

How Predictive Analytics is Boosting Clinical Trials Efficiency?

Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is reshaping the landscape of clinical trials, ushering in a ...

BySOPHiA Genetics


The Importance of Data Diversity to Enhance Clinical Trials Success

The Importance of Data Diversity to Enhance Clinical Trials Success

Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. ...

BySOPHiA Genetics


How to Submit Sequence Data to GenBank   

How to Submit Sequence Data to GenBank  

Submission of sequence data to NCBI archives Next-generation sequencing, PacBio SMRT sequencing, and Nanopore sequencing, can generate numerous sequence data in a single run. Raw reads or assembled sequence need to be submitted to public sequence repository (DDBJ/ENA/GenBank - INSDC), which is required by the overwhelming majority of journals as accession ...

ByCD Genomics


From Data to Decisions, Faster than Ever: Pioneering the future of precision medicine with the New Generation SOPHiA DDM Platform

From Data to Decisions, Faster than Ever: Pioneering the future of precision medicine with the New Generation SOPHiA DDM Platform

In response to the emerging needs in global healthcare, SOPHiA GENETICS has just revealed the New Generation SOPHiA DDM™ Platform, aiming to stay at the forefront of precision medicine and address today the healthcare needs of tomorrow. ...

BySOPHiA Genetics


Customer Spotlight: Laboratory of Genetics and Genomics, Cagliari

Customer Spotlight: Laboratory of Genetics and Genomics, Cagliari

We recently spoke with Manuela Badiali, Rita Congiu, and Stefania Murru from the Laboratory of Genetics and Genomics, Microcitemico Pediatric Hospital – A. Cao, Cagliari, about how SOPHiA DDM™ RNAtarget Technology has helped them optimize their variant analysis workflow. ...

BySOPHiA Genetics


Flu, COVID-19, and RSV in the U.S.: Insights from the Latest Surveillance Season

Flu, COVID-19, and RSV in the U.S.: Insights from the Latest Surveillance Season

Welcome to 2023-2024 season’s respiratory surveillance recap, where we’ll share insights from the most recent respiratory surveillance season, covering three major respiratory viruses: COVID-19, influenza, and RSV. Tracking these illnesses is imperative for maintaining population health because these illnesses significantly impact individual wellbeing and healthcare costs, resource ...

ByBiobot Analytics, Inc.


Using artificial intelligencepowered evidence-based molecular decision-making for improved outcomes in ovarian cancer

Using artificial intelligencepowered evidence-based molecular decision-making for improved outcomes in ovarian cancer

Only 20% of patients with ovarian HGSC will be long-term survivors, but no current clinical data can accurately predict which patient will be a short- or long-term survivor. ...

ByPredictive Oncology Inc.


Host Cell Protein Risks and Testing Requirements

Host Cell Protein Risks and Testing Requirements

Almost all HCPs are foreign proteins with clinical safety risks due to their potential to trigger an immune response in the body. ...

ByCreative Proteomics


Clinical Data Management: What Are The Key Challenges And How To Navigate Them?

Clinical Data Management: What Are The Key Challenges And How To Navigate Them?

One of the biggest challenges clinical data management faces is the sheer amount of data that needs to be processed. ...

ByClinion


From Raw Data to Actionable Insights: Biobot’s Evolution of Public Data Sharing

From Raw Data to Actionable Insights: Biobot’s Evolution of Public Data Sharing

Biobot has always believed in the transformative power of wastewater data for public health. We started by making this important data available during the COVID-19 pandemic to fill critical data gaps nationally in an easily digestible way. ...

ByBiobot Analytics, Inc.


Speeding Up Healthcare Innovation Leveraging Cloud Technology

Speeding Up Healthcare Innovation Leveraging Cloud Technology

Over the past decade, cloud computing has undergone remarkable expansion. The collective revenue generated by AWS, Google Cloud, and Microsoft surged from $49 billion in 2018 to an astonishing $206 billion in 2022.[i] Projections from Future Market Insights indicate that the revenue from cloud services is poised to maintain an impressive average annual growth rate of 21%, reaching a staggering ...

ByCaresyntax


Top Advances in Echocardiography Transforming Cardiac Imaging on World Heart Day

Top Advances in Echocardiography Transforming Cardiac Imaging on World Heart Day

In honor of World Heart Day on September 29, we're diving into the world of cardiovascular diagnostics. Echocardiography, one of the most widely used screening and diagnostic modalities in healthcare, has seen a resurgence thanks to advances and groundbreaking innovations within the last few years. Join us as we explore the top trends shaping these diagnostic methods. 1. ...

ByUltromics Limited


Autoimmune Diseases Targets

Autoimmune Diseases Targets

In the treatment of severe asthma, Tezspire is the only biologic therapy without phenotype or biomarker restrictions, which indicates that more severe asthma patients have the opportunity to receive treatment. Clinical data has shown that Tezspire can significantly improve symptoms. ...

ByBeta Lifescience


Development Trends And Potential Challenges of PROTACs

Development Trends And Potential Challenges of PROTACs

The Development Trend of PROTAC Verify the degradation of "non-druggable proteins" in clinical trials: At present, PROTAC molecules that have entered the clinical trial stage mainly target traditional AR, ER, BTK, etc. ...

ByBiopharma PEG Scientific Inc


Navigating the Bioinformatics Workflow for Whole Exome Sequencing: A Step-by-Step Guide

Navigating the Bioinformatics Workflow for Whole Exome Sequencing: A Step-by-Step Guide

Raw data quality control Sequence data generally has two common standard formats: FASTQ and FASTA. ...

ByCD Genomics


Significance of Diagnostic Enzyme Detection

Significance of Diagnostic Enzyme Detection

Serum enzyme tests have been used in clinical practice for a long time, such as increased amylase activity in serum and urine of patients with acute pancreatitis. ...

ByCreative Enzymes


How can Nuvonis help to fight the SARS-CoV-2 pandemics?

How can Nuvonis help to fight the SARS-CoV-2 pandemics?

Most of these products are in early stage of development against SARS-CoV-2, but already have acquired clinical data (mostly phase 1 or 2) in other indications. One of the major challenges is the manufacturing of a new SARS-CoV-2 vaccine in large scale for global demand. ...

ByNuvonis


Indication selection for anti-PDx combination therapy In collaboration with big pharma - Case Study

Indication selection for anti-PDx combination therapy In collaboration with big pharma - Case Study

The Challenge: One of the most common challenges in immuno-oncology is identifying the indications and patient populations that would benefit from a specific therapy, especially on top of Standard of Care (SOC) treatments. Our platform tackled this challenge of indication prioritization and patient stratification for a combination of a specific target (A) with an anti-PDX drug that one of our ...

ByCytoReason


The Future of Quantitative Susceptibility Mapping (QSM) in Clinical Applications

The Future of Quantitative Susceptibility Mapping (QSM) in Clinical Applications

The use of Quantitative Susceptibility Mapping (QSM) is often viewed as incompatible with current standard radiology workflows. Some radiologists or departments may be unaware of its existence or purpose. Despite the skepticism surrounding its viability in a clinical setting, QSM shows great potential in a wide range of clinical applications, particularly for biomarker detection and ...

BySpinTech, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT